- Labopharm's Ryzolt pain reliever approved by Food and Drug Administration (Canadian Business)
MONTREAL - Labopharm Inc. (TSX:DDS) says its flagship drug Ryzolt, a once-daily formulation of the painkiller Tramadol, has been approved for sale
- Labopharm's Ryzolt pain reliever approved by FDA (CTV.ca)
Labopharm Inc. has won U.S. Food and Drug Administration approval of Ryzolt, the Montreal-area company's once-daily formulation of painkiller Tramadol.
- Labopharm's Ryzolt pain reliever approved (Toronto Star)
Investors in Labopharm Inc. held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt, its once-daily formulation of painkiller tramadol.
- Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of ... (CNW Group via Yahoo! Finance)
Labopharm Inc. today announced that RYZOLT , Labopharm's once-daily formulation of the analgesic tramadol, has been approved by the U.S. Food and Drug Administration . RYZOLT is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.
- Labopharm's Ryzolt pain reliever approved by Food and Drug Administration (Canoe Money)
MONTREAL - Labopharm Inc. (TSX:DDS) says its flagship drug Ryzolt, a once-daily formulation of the painkiller tramadol, has been approved for sale in the world's biggest market for pharmaceuticals.
- Labopharm's chronic pain drug Ryzolt receives US FDA approval (PharmaBiz)
Labopharm Inc announced that Ryzolt (tramadol HCl extended release tablets), Labopharm's once-daily formulation of the analgesic tramadol, has been approved by the US Food and Drug Administration (FDA). Ryzolt is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.
- Biovail recalls certain lots of Ultram ER 100mg tabs (PharmaBiz)
Biovail Corporation announced a voluntary recall of certain lots of Ultram ER (extended-release tramadol hydrochloride) 100mg tablets from pharmacies and wholesalers.
- Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 ... (PR Newswire via Yahoo! Finance)
Labopharm Inc. today announced that it will host a conference call on Tuesday, January 6, 2009 at 8:30 a.m. to discuss the U.S. Food and Drug Administration's approval of its once-daily formulation of Tramadol, RYZOLT.